8:11 AM ET
8-K
Executive Compensation
MBX Biosciences Executive Compensation
MBX Biosciences appointed Peter Radovich to its Board of Directors as a Class I director, effective October 20, 2026. In connection with his appointment, Mr. Radovich received an initial grant of non-qualified stock options for 18,200 shares and will receive cash compensation according to the company's non-employee director compensation policy.
- Counterparty
- Peter Radovich